Crossover Trial of AD036 in Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

AD036

Oral administration before bed

DRUG

Atomoxetine

Oral administration before bed

DRUG

Placebo

Oral administration before bed

Trial Locations (5)

20815

The Center for Sleep and Wake Disorders, Chevy Chase

45212

CTI Clinical Research Center, Cincinnati

63017

Sleep Medicine & Research Center, St. Luke's Hospital, Chesterfield

72211

Preferred Research Partners, Inc., Little Rock

92705

SDS Clinical Trials, Inc., Santa Ana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Apnimed

INDUSTRY